Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asaf Caspi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Archives of General Psychiatry|December 7, 2005
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophreniaAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Schizophrenia Research|April 22, 2006
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based studyAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
International Journal of Environmental Research and Public Health|October 21, 2020
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant SchizophreniaAnna Alonso-Solís, Susana Ochoa, Eva Grasa, et al.
JMIR Mhealth and Uhealth|September 30, 2016
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative StudyElena Huerta-Ramos, Maria Soledad Escobar-Villegas, Katya Rubinstein, et al.
JMIR Human Factors|May 15, 2025
Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy StudyJussi Seppälä, Eva Grasa, Anna Alonso-Solis, et al.
BMJ Open|July 18, 2018
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregiversAnna Alonso-Solís, Katya Rubinstein, Iluminada Corripio, et al.
JMIR Formative Research|June 30, 2023
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability StudyEva Grasa, Jussi Seppälä, Anna Alonso-Solis, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Archives of General Psychiatry|December 7, 2005
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophreniaAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
Schizophrenia Research|April 22, 2006
Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based studyAbraham Reichenberg, Mark Weiser, Michael A Rapp, et al.
International Journal of Environmental Research and Public Health|October 21, 2020
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant SchizophreniaAnna Alonso-Solís, Susana Ochoa, Eva Grasa, et al.
JMIR Mhealth and Uhealth|September 30, 2016
Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative StudyElena Huerta-Ramos, Maria Soledad Escobar-Villegas, Katya Rubinstein, et al.
JMIR Human Factors|May 15, 2025
Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy StudyJussi Seppälä, Eva Grasa, Anna Alonso-Solis, et al.
BMJ Open|July 18, 2018
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregiversAnna Alonso-Solís, Katya Rubinstein, Iluminada Corripio, et al.
JMIR Formative Research|June 30, 2023
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability StudyEva Grasa, Jussi Seppälä, Anna Alonso-Solis, et al.
Pageof 3